Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction

BACKGROUND: Streptokinase (SK) is an effective fibrinolytic agent for the treatment of acute myocardial infarction (AMI). The objective of the present study was to assess the adverse drug reactions (ADRs) associated with intravenous recombinant SK in patients with AMI in routine clinical practice. M...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Betancourt, Blas Y, Marrero-Miragaya, María A, Jiménez-López, Giset, Valenzuela-Silva, Carmen, García-Iglesias, Elizeth, Hernández-Bernal, Francisco, Debesa-García, Francisco, González-López, Tania, Alvarez-Falcón, Leovaldo, López-Saura, Pedro A
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2005
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1291362/
https://ncbi.nlm.nih.gov/pubmed/16262910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6904-5-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker